Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jurgen Ventiz
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer
Journal of Clinical Pharmacology
Pharmacology
Related publications
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I/Ii Study of Oncolytic Herpes Simplex Virus NV1020 in Patients With Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
Clinical Breast Cancer
Cancer Research
Oncology
A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Pembrolizumab Combined With Lenalidomide and Low‐dose Dexamethasone for Relapsed or Refractory Multiple Myeloma: Phase I KEYNOTE ‐023 Study
British Journal of Haematology
Hematology
Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study
British Journal of Cancer
Cancer Research
Oncology
